Company Filing History:
Years Active: 2023
Title: Katharina Ochs: Innovator in Cancer Vaccine Development
Introduction
Katharina Ochs is a prominent inventor based in Heidelberg, Germany. She has made significant contributions to the field of cancer research, particularly in the development of innovative vaccines targeting cancer diseases. Her work focuses on harnessing the immune system to combat malignancies, including glioma.
Latest Patents
Katharina Ochs holds a patent for her invention titled "Histone anti-cancer vaccines." This groundbreaking invention pertains to novel immunogenic peptide sequences that can be utilized as vaccines in the treatment of various cancer diseases, specifically brain cancers such as glioma. The cancer vaccines are designed based on the K27M mutated variant of human Histone 3. The patent also includes fusion proteins comprising the sequences of the cancer vaccines, nucleic acids encoding such vaccines, and vectors and host cells that incorporate these sequences. Furthermore, the invention addresses T cells and T cell receptors that bind to the cancer vaccines, particularly when presented by the human Major Histocompatibility Complex (MHC). The peptide immunogens elicit a HLA-restricted immune response, making them valuable in treating cancer diseases, especially glioma. Additional aspects of the invention involve pharmaceutical compositions and diagnostic methods based on the immunogenic capacity of the disclosed peptides.
Career Highlights
Throughout her career, Katharina Ochs has worked with esteemed institutions, including the German Cancer Research Center (Deutsches Krebsforschungszentrum) and the German Cancer Research Center Foundation of Public Law (Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts). Her dedication to cancer research has positioned her as a key figure in the field.
Collaborations
Katharina has collaborated with notable colleagues, including Michael Platten and Theresa Bunse. These partnerships have furthered her research and contributed to advancements in cancer treatment.
Conclusion
Katharina Ochs is a trailblazer in the development of cancer vaccines, with her innovative work paving the way for new therapeutic approaches. Her contributions to the field of immunology and cancer research are invaluable and continue to inspire future advancements.